Kobayashi, Mizuki
Numakura, Kazuyuki
Hatakeyama, Shingo
Ishida, Toshiya
Koizumi, Atsushi
Tadachi, Kazuki
Igarashi, Ryoma
Takayama, Koichiro
Muto, Yumina
Sekine, Yuya
Sobu, Ryuta
Sasagawa, Hajime
Akashi, Hideo
Kashima, Soki
Yamamoto, Ryohei
Nara, Taketoshi
Saito, Mitsuru
Narita, Shintaro
Ohyama, Chikara
Habuchi, Tomonori
Funding for this research was provided by:
the Grants-in-Aid for Scientific Research (20K09553)
Article History
Received: 20 June 2023
Accepted: 27 July 2023
First Online: 8 August 2023
Declarations
:
: Dr. Habuchi received honoraria from Novartis Pharma, Pfizer Co., GlaxoSmithKline, and Ono Pharma Co. Other authors have no conflicts of interest.
: Approval of the research protocol by an Institutional Reviewer Board: This study was approved by five institutional review boards (ID: 2245 in the Institutional Review Board of the Akita University Graduate School of Medicine).
: Informed consent was not required for this retrospective study; however, efforts were made to obtain it from the participants, or they were notified via websites following the opt-out policy (ExternalRef removed). All procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki.